Royal Victorian Eye and Ear Hospital, Melbourne, Victoria, Australia.
Otol Neurotol. 2010 Feb;31(2):216-9. doi: 10.1097/MAO.0b013e3181c348e7.
To investigate the results of cochlear implantation in patients with neurofibromatosis Type 2 (NF2) who have previously been treated with radiation therapy to the vestibular schwannoma (VS) in their only hearing ear.
A retrospective review of the Melbourne Cochlear implant database was undertaken to identify patients with NF2 undergoing cochlear implantation in whom previous radiation therapy had been performed to control their VS (ipsilateral tumor). Three patients were identified. A case note review was undertaken and data collected on preoperative and postoperative speech perception testing.
Melbourne Cochlear implant center.
All 3 patients were daily cochlear implant users. There was improvement in speech perception scores in 2 cases, with the 3rd case unable, for unrelated medical reasons, to complete postoperative testing. Subjectively, the third patient reported a dramatic improvement in communication and is a daily user of his implant.
Cochlear implantation results in improved hearing in a select group of NF2 patients who have undergone radiation treatment to control their VS.
研究在单侧听神经瘤(VS)接受过放射治疗的神经纤维瘤病 2 型(NF2)患者中进行耳蜗植入的结果。
对墨尔本耳蜗植入数据库进行回顾性研究,以确定接受 NF2 耳蜗植入的患者,其 VS(同侧肿瘤)曾接受过放射治疗。确定了 3 名患者。进行了病历回顾,并收集了术前和术后言语感知测试的数据。
墨尔本耳蜗植入中心。
所有 3 例患者均为每日耳蜗植入使用者。在 2 例患者中,言语感知评分有所改善,第 3 例患者由于无关的医疗原因无法完成术后测试。主观上,第 3 例患者报告说他的沟通能力有了显著提高,并且是他植入物的日常使用者。
在接受放射治疗以控制 VS 的 NF2 患者中,选择一组患者进行耳蜗植入可获得听力改善。